Gemcitabine and Nab-paclitaxel Combined With Momelotinib in Participants With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma
Clinical trial NCT02101021 · TERMINATED
Trial details
- NCT number
- NCT02101021
- Sponsor
- Sierra Oncology LLC - a GSK company
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-02
- Primary completion
- 2017-04-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.